Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2013 1
2017 1
2018 3
2021 1
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Results by year

Filters applied: . Clear all
Page 1
Mortality and risk factors of vaccinated and unvaccinated frail patients with COVID-19 treated with anti-SARS-CoV-2 monoclonal antibodies: A real-world study.
Nevola R, Feola G, Ruocco R, Russo A, Villani A, Fusco R, De Pascalis S, Core MD, Cirigliano G, Pisaturo M, Loffredo G, Rinaldi L, Marrone A, Starace M, Sposito PL, Cozzolino D, Salvatore T, Lettieri M, Marfella R, Sasso FC, Coppola N, Adinolfi LE. Nevola R, et al. Among authors: sposito pl. Int J Infect Dis. 2023 Jun;131:155-161. doi: 10.1016/j.ijid.2023.03.030. Epub 2023 Mar 20. Int J Infect Dis. 2023. PMID: 36944382 Free PMC article.
Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study.
Raparelli V, Pastori D, Pignataro SF, Vestri AR, Pignatelli P, Cangemi R, Proietti M, Davì G, Hiatt WR, Lip GYH, Corazza GR, Perticone F, Violi F, Basili S; ARAPACIS Study Collaborators. Raparelli V, et al. Intern Emerg Med. 2018 Aug;13(5):651-660. doi: 10.1007/s11739-018-1835-9. Epub 2018 Mar 26. Intern Emerg Med. 2018. PMID: 29582316
Prevalence of peripheral artery disease by abnormal ankle-brachial index in atrial fibrillation: implications for risk and therapy.
Violi F, Daví G, Hiatt W, Lip GY, Corazza GR, Perticone F, Proietti M, Pignatelli P, Vestri AR, Basili S; ARAPACIS Study Investigators. Violi F, et al. J Am Coll Cardiol. 2013 Dec 10;62(23):2255-6. doi: 10.1016/j.jacc.2013.07.035. Epub 2013 Aug 14. J Am Coll Cardiol. 2013. PMID: 23954332 Free article. No abstract available.
[Generic drugs in Brazil: historical overview and legislation].
Araújo LU, Albuquerque KT, Kato KC, Silveira GS, Maciel NR, Spósito PÁ, Barcellos NM, Souza Jd, Bueno M, Storpirtis S. Araújo LU, et al. Among authors: sposito pa. Rev Panam Salud Publica. 2010 Dec;28(6):480-92. doi: 10.1590/s1020-49892010001200010. Rev Panam Salud Publica. 2010. PMID: 21308175 Portuguese.
Correction to: Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study.
Raparelli V, Pastori D, Pignataro SF, Vestri AR, Pignatelli P, Cangemi R, Proietti M, Davì G, Hiatt WR, Lip GYH, Corazza GR, Perticone F, Violi F, Basili S; ARAPACIS Study Collaborators. Raparelli V, et al. Intern Emerg Med. 2018 Dec;13(8):1349. doi: 10.1007/s11739-018-1922-y. Intern Emerg Med. 2018. PMID: 30076553